Cevimeline

Cevimeline | CAS NO: 107233-08-9 , Cevimeline (brand name Evoxac) is an FDA-approved, oral cholinergic agonist used to treat dry mouth (xerostomia) in patients with Sjögren’s syndrome. By acting on M3 muscarinic receptors in salivary glands, it increases saliva production, improving swallowing and speaking. The typical dosage is 30 mg three times daily. 

We are the Synchemia Research Chemical specializes in manufacturing and supplying of Cevimeline  impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities. Cevimeline (brand name Evoxac) is an FDA-approved, oral cholinergic agonist used to treat dry mouth (xerostomia) in patients with Sjögren’s syndrome. By acting on M3 muscarinic receptors in salivary glands, it increases saliva production, improving swallowing and speaking. The typical dosage is 30 mg three times daily.  Buy Reliable and High-Purity Cevimeline Impurities, Delivered by Synchemia Research Chemicals.